Research explores the resilience of the H5N1 influenza virus in milk under pasteurization conditions, showing effective viral inactivation at standard temperatures but highlighting the need for further real-world testing.
Progentos emerges with $65M for multiple sclerosis trials with IP from Frequency
A new biotech emerged to take forward the lead preclinical work developed by Frequency Therapeutics, a regenerative medicines company that gave up its Nasdaq spot